Product Reports Resources Pricing Login Book a demo

Deepcell

Biotech & Life Sciences · Sunnyvale, United States · Founded 2015

Aims to provide detailed genetic health information through ordinary blood sampling MoreLess

Deepcell is a biotechnology startup that operates in the field of cell analysis and sorting. The company's primary product is the REM-I platform, a cutting-edge technology that combines label-free imaging, deep learning, and gentle sorting to analyze and categorize cells based on their morphology, or shape and structure. This technology allows for a high-dimensional quantitative readout, meaning it can provide detailed and comprehensive data about individual cells.

Deepcell's technology is built on advanced microfluidics, a technique that manipulates tiny droplets of fluid in a controlled way, and artificial intelligence (AI). The AI component of the REM-I platform uses deep learning, a type of machine learning that mimics the workings of the human brain, to analyze and interpret the data gathered from the cell imaging. This combination of technologies allows for deep characterization of cells, providing valuable insights for researchers and scientists.

The company's clients are likely to be in the scientific and medical research fields, where detailed cell analysis is crucial. For example, pharmaceutical companies developing new drugs, or academic researchers studying diseases at a cellular level, could benefit from Deepcell's technology.

Deepcell's business model is likely based on selling or licensing its REM-I platform to these clients. The company may also generate revenue from providing data analytics services, using the powerful data gathered from its cell imaging technology to provide clients with detailed reports and insights.

In summary, Deepcell is a biotech startup that uses advanced technology to provide detailed cell analysis and sorting services. Its combination of microfluidics, AI, and data analytics makes it a leader in its field, and its REM-I platform is likely to be in high demand among scientific and medical researchers.

Keywords: Biotechnology, Cell Analysis, Cell Sorting, REM-I Platform, Microfluidics, Deep Learning, Artificial Intelligence, Data Analytics, Scientific Research, Medical Research.

Company overview

Deepcell company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2015
Headquarters
Sunnyvale, United States
Employees
33
Open positions
None listed
Dealroom signal
69.9
client focusb2btechnologyArtificial IntelligencetechnologyHardwaretechnologyDeep Techsub industryBioTechnologysub industryMedical Devicesbusiness modelSaaSsectorTestingindustryHealthsectorBiotechnologysectorDrug DevelopmentsectorGenetics and genomicssectorCore AIsectorPrecision Medicine

Valuation & funding

Deepcell funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Oct 2022 $80M $320M Undisclosed
SERIES BOther financing Mar 2022 $73M $292M Matt McIlwain · Bridger Healthcare · Horizons Ventures · Andreessen Horowitz
SERIES AOther financing Dec 2020 $20M $80M Jeff Dean · DCVC · Andreessen Horowitz · Fifty Years
SEEDOther financing Jun 2019 Undisclosed
SEEDOther financing Feb 2018 $5M $20M Andreessen Horowitz
SPINOUTOther financing Nov 2015 Stanford University
Showing 6 recorded eventsUnlock the complete deal history →

Growth signals

Deepcell website traffic

Latest recorded traffic for Deepcell is 260 monthly website visits, up 13% over the last three months. Deepcell's team declined 19.5% over the past year.

Latest monthly visits260 3-month web change+13% 1-year team growth-19.5%
Monthly website visits55 observations · Oct 2017–Jun 2024
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Deepcell compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Deepcell's talent

Book a demo to see the people
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Deepcell's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 9 investors entered at this stage
Jeff Dean
DCVC
Fifty Years
Bow Capital
Matt McIlwain
Bridger Healthcare
Horizons Ventures
Casdin Capital
Koch Disruptive Technologies
Other known 1 additional known investor
Stanford University

Global footprint

Where Deepcell has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States97.1%
🇭🇰 Hong Kong2.9%
2 countries shown

In the news

Latest news about Deepcell

Recent press, funding announcements, and product moves mentioning Deepcell — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Deepcell

An AI-synthesized read of the highest-engagement posts about Deepcell on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Deepcell’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.